Jan 5 (Reuters) - Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna , filed for an initial public offering in the United States on Friday. (Reporting by Niket Nishant in Bengaluru; Editing by Pooja Desai)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
142.6 USD | -5.89% | -14.43% | +43.36% |
May. 31 | Health Care Stocks Climb On Drug News -- Health Care Roundup | DJ |
May. 31 | Equities Mostly Rise as Fed's Preferred Inflation Measure Meets Street Views | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
142.6 USD | -5.89% | -14.43% | 54.63B | ||
28.24 EUR | +0.66% | +2.21% | 30.09B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna-backed genetic drugs firm Metagenomi files for US IPO